Bempegaldesleukin
20-214-36
Phase 3 small_molecule terminated
Quick answer
Bempegaldesleukin for Metastatic Head and Neck Cancer is a Phase 3 program (small_molecule) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nektar Therapeutics UK Limited
- Indication
- Metastatic Head and Neck Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated